News

Healio16y
Fifty years of beta-blockers: a revolution in CV pharmacotherapy
Beta-adrenergic blockers function as competitive pharmacologic ... for cardiac beta 1-receptors (metoprolol, atenolol), partial adrenergic agonist activity (pindolol), concomitant alpha-adrenergic ...
Business Wire6y
Estrogen Receptor Beta Partial Agonist Pipeline Insights, 2018 Report Featuring Ausio Pharmaceuticals, AstraZeneca, ENDECE, ACADIA Pharmaceuticals & Eli Lilly ...
DUBLIN--(BUSINESS WIRE)--The "Estrogen Receptor Beta Partial Agonist -Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. Estrogen Receptor Beta Partial ...
Nature10y
Expression of the 5-HT1A Serotonin Receptor in the Hippocampus Is Required for Social Stress Resilience and the Antidepressant-Like Effects Induced by the Nicotinic Partial ...
Therefore, decreasing ACh signaling through these receptors while preserving some function, as can be achieved by treating with a nicotinic partial agonist such as cytisine or varenicline ...
Reuters17y
CV Therapeutics announces that Adenosine A1 agonist Tecadenoson shows synergistic effect with ultra low dose beta blocker in preclinical atrial fibrillation model
Co announces that data from a preclinical study of the selective adenosine A1 agonist tecadenoson, in combination with a low dose of the beta blocker metoprolol, showed increased rate control ...